NGNE vs. WSM
Compare and contrast key facts about Neurogene Inc (NGNE) and Williams-Sonoma, Inc. (WSM).
Performance
NGNE vs. WSM - Performance Comparison
Loading graphics...
NGNE vs. WSM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NGNE Neurogene Inc | -2.14% | -9.89% | 17.96% | 90.37% | -89.44% | -65.82% | 14.45% | 470.37% | -81.63% | -28.77% |
WSM Williams-Sonoma, Inc. | 1.32% | -2.09% | 86.56% | 80.24% | -30.49% | 68.60% | 42.38% | 50.07% | 0.61% | 10.20% |
Fundamentals
NGNE:
$312.27M
WSM:
$21.82B
NGNE:
-$4.70
WSM:
$8.84
NGNE:
1.18
WSM:
10.48
NGNE:
$0.00
WSM:
$7.81B
NGNE:
-$787.00K
WSM:
$3.60B
NGNE:
-$90.05M
WSM:
$1.55B
Returns By Period
In the year-to-date period, NGNE achieves a -2.14% return, which is significantly lower than WSM's 1.32% return. Over the past 10 years, NGNE has underperformed WSM with an annualized return of -20.18%, while WSM has yielded a comparatively higher 23.64% annualized return.
NGNE
- 1D
- 4.46%
- 1M
- -14.18%
- YTD
- -2.14%
- 6M
- 16.33%
- 1Y
- 72.16%
- 3Y*
- 12.92%
- 5Y*
- -39.64%
- 10Y*
- -20.18%
WSM
- 1D
- -1.07%
- 1M
- -10.42%
- YTD
- 1.32%
- 6M
- -7.03%
- 1Y
- 15.29%
- 3Y*
- 46.29%
- 5Y*
- 16.84%
- 10Y*
- 23.64%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NGNE vs. WSM — Risk / Return Rank
NGNE
WSM
NGNE vs. WSM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Neurogene Inc (NGNE) and Williams-Sonoma, Inc. (WSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NGNE | WSM | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.68 | 0.38 | +0.30 |
Sortino ratioReturn per unit of downside risk | 1.75 | 0.82 | +0.94 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.10 | +0.09 |
Calmar ratioReturn relative to maximum drawdown | 0.74 | 0.77 | -0.03 |
Martin ratioReturn relative to average drawdown | 1.37 | 1.73 | -0.36 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| NGNE | WSM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.68 | 0.38 | +0.30 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.43 | 0.38 | -0.81 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.23 | 0.54 | -0.77 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.11 | 0.33 | -0.45 |
Correlation
The correlation between NGNE and WSM is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
NGNE vs. WSM - Dividend Comparison
NGNE has not paid dividends to shareholders, while WSM's dividend yield for the trailing twelve months is around 1.46%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NGNE Neurogene Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
WSM Williams-Sonoma, Inc. | 1.46% | 1.43% | 1.16% | 1.72% | 2.65% | 1.43% | 1.93% | 2.55% | 3.33% | 2.98% | 3.02% | 2.36% |
Drawdowns
NGNE vs. WSM - Drawdown Comparison
The maximum NGNE drawdown since its inception was -98.34%, which is greater than WSM's maximum drawdown of -89.01%. Use the drawdown chart below to compare losses from any high point for NGNE and WSM.
Loading graphics...
Drawdown Indicators
| NGNE | WSM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.34% | -89.01% | -9.33% |
Max Drawdown (1Y)Largest decline over 1 year | -52.37% | -20.56% | -31.81% |
Max Drawdown (5Y)Largest decline over 5 years | -97.20% | -51.92% | -45.28% |
Max Drawdown (10Y)Largest decline over 10 years | -98.14% | -59.71% | -38.43% |
Current DrawdownCurrent decline from peak | -95.45% | -18.26% | -77.19% |
Average DrawdownAverage peak-to-trough decline | -67.40% | -25.10% | -42.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.38% | 9.15% | +19.23% |
Volatility
NGNE vs. WSM - Volatility Comparison
Neurogene Inc (NGNE) has a higher volatility of 22.23% compared to Williams-Sonoma, Inc. (WSM) at 8.55%. This indicates that NGNE's price experiences larger fluctuations and is considered to be riskier than WSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| NGNE | WSM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.23% | 8.55% | +13.68% |
Volatility (6M)Calculated over the trailing 6-month period | 66.32% | 23.85% | +42.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 108.56% | 40.82% | +67.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 92.98% | 44.73% | +48.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 87.46% | 44.19% | +43.27% |
Financials
NGNE vs. WSM - Financials Comparison
This section allows you to compare key financial metrics between Neurogene Inc and Williams-Sonoma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities